ADVI Health Attending Informa Connect’s Pricing and Contracting USA 2026 Conference

From May 18-20, 2026, ADVI Health’s Alicia Silver, vice president, emerging therapies, and Siya Bhatt, director of business development, will be attending Informa Connect’s Life Sciences Pricing and Contracting USA 2026 Conference in Philadelphia, PA.

On Wednesday, May 20, from 11-11:40 am ET, Alicia will be participating in the session, “Cell and Gene Therapies Market Access State of Affairs,” alongside Manishi Prasad, vice president of market access and public policy at Beam Therapeutics. The session will:

    • Explore market access strategies as CAR-T therapies expand into autoimmune conditions
    • Build compelling value propositions
    • Tackle the margin pressures hospitals face with CGT administration
    • Explore innovative contracting models beyond traditional outcomes-based agreements
    • Create collaborative frameworks that address price protection requests, streamline prior authorization processes, and support centers in navigating the complex reimbursement landscape

ADVI Team

Alicia Silver, MPP

Vice President, Emerging Therapies

Siya Bhatt

Director

Further Resources:

ADVI insights

Insights,

| Marc Samuels, JD, MPH - Chief Executive Officer

The 2026 Rare Disease Reality

Insights,

| Stacey Gilbert, MPH, MBA - Director, Precision Medicine

FDA Proposes Down-Classification of Oncology Companion Diagnostics: A Q&A on Precision Medicine

Insights,

| Marc Samuels, JD, MPH - Chief Executive Officer

2026 Life Sciences Forecast: AI, Next-Gen Cell & Gene Therapy, and Policy Disruption

Insights,

| Alicia Silver, MPP - Vice President, Emerging Therapies

Delivering on CAR T-cell Therapy’s Promise: Policy Solutions for the Next Era of Cancer Care